Medical management of brain tumor patients.
Brain tumors can present challenging medical problems. Seizures, peritumoral edema, venous thromboembolism, fatigue, and cognitive dysfunction can complicate the treatment of patients who have primary or metastatic brain tumors. Effective medical management results in decreased morbidity and mortality and improved quality of life for affected patients.
Drappatz
Jan
J
Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. jdrappatz@partners.org
Schiff
David
D
Kesari
Santosh
S
Norden
Andrew D
AD
Wen
Patrick Y
PY
D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001929:Brain Edema / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D001932:Brain Neoplasms / Q000150:complications* / Q000188:drug therapy*; D003072:Cognition Disorders / Q000209:etiology*; D003863:Depression / Q000188:drug therapy* / Q000209:etiology*; D003937:Diagnosis, Differential; D004347:Drug Interactions; D005221:Fatigue / Q000209:etiology*; D006801:Humans; D008279:Magnetic Resonance Imaging; D012640:Seizures / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D054556:Venous Thromboembolism / Q000188:drug therapy* / Q000209:etiology*
D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D000928:Antidepressive Agents; D000970:Antineoplastic Agents